Roche’s CellCept Gains “Black Box” Warning On Use During Pregnancy
FDA reinforces warning on increased risk of miscarriage, congenital deformities in light of postmarketing data from Roche, firm tells “The Pink Sheet” DAILY.
FDA reinforces warning on increased risk of miscarriage, congenital deformities in light of postmarketing data from Roche, firm tells “The Pink Sheet” DAILY.